Durability of anti-spike antibodies after vaccination with mRNA SARS-CoV-2 vaccine is longer in subjects with previous infection: could the booster dose be delayed?

[1] Polack FP(2020)Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine N Engl J Med 383 2603-2615

[2] Thomas SJ(2021)BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting N Engl J Med 384 1412-1423

[3] Kitchin N(2021)Spike-antibody waning after second dose of BNT162b2 or ChAdOx1 Lancet 398 385-387

[4] Dagan N(2021)Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months N Engl J Med 385 2261-2018

[5] Barda N(2021)mRNA vaccine-elicited SARS-CoV-2-specific T cells persist at 6 months and recognize the delta variant Clin Infect Dis 13 2010-462

[6] Kepten E(2021)Prior SARS-CoV-2 infection increases reactogenicity after SARS-COV-2 mRNA vaccine and could delay the administration of the vaccine based on timing of infection Infection 59 eabf4063-undefined

[7] Shrotri M(2021)Robust and persistent B- and T-cell responses after COVID-19 in immunocompetent and solid organ transplant recipient patients Viruses 371 457-undefined

[8] Navaratnam AMD(2021)Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine Clin Chem Lab Med 584 undefined-undefined

[9] Nguyen V(2021)Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection Science undefined undefined-undefined

[10] Levin EG(2020)SARS-CoV-2 specific T cell immunity in case of COVID-19 and SARS, and uninfected controls Nature undefined undefined-undefined

[1] Polack FP(2020)Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine N Engl J Med 383 2603-2615

[2] Thomas SJ(2021)BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting N Engl J Med 384 1412-1423

[3] Kitchin N(2021)Spike-antibody waning after second dose of BNT162b2 or ChAdOx1 Lancet 398 385-387

[4] Dagan N(2021)Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months N Engl J Med 385 2261-2018

[5] Barda N(2021)mRNA vaccine-elicited SARS-CoV-2-specific T cells persist at 6 months and recognize the delta variant Clin Infect Dis 13 2010-462

[6] Kepten E(2021)Prior SARS-CoV-2 infection increases reactogenicity after SARS-COV-2 mRNA vaccine and could delay the administration of the vaccine based on timing of infection Infection 59 eabf4063-undefined

[7] Shrotri M(2021)Robust and persistent B- and T-cell responses after COVID-19 in immunocompetent and solid organ transplant recipient patients Viruses 371 457-undefined

[8] Navaratnam AMD(2021)Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine Clin Chem Lab Med 584 undefined-undefined

[9] Nguyen V(2021)Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection Science undefined undefined-undefined

[10] Levin EG(2020)SARS-CoV-2 specific T cell immunity in case of COVID-19 and SARS, and uninfected controls Nature undefined undefined-undefined